Food News and Research

RSS

1 in 4 survey participants secretly create concoctions

A study from the University of Alabama at Birmingham (UAB) suggests food concocting - the making of strange food mixtures like mashed potatoes and Oreo cookies, frozen vegetables mixed with mayonnaise, and chips with lemon, pork rinds, Italian dressing and salt - is common among binge eaters. The findings, available online and to be published in the International Journal of Eating Disorders, reveal that 1 in 4 survey participants secretly create concoctions.

4 Jan 2013

Confusion surrounds regulation of various types of drug makers

Far from triggering a quick fix, the deaths or illnesses of 620 people in 19 states that have been linked to a Massachusetts pharmacy have only underscored confusion over how to regulate the various types of drug-makers in the United States.

4 Jan 2013

ParoChip can allow dentists to quickly detect and analyze periodontitis pathogens

Bleeding gums during tooth brushing or when biting into an apple could be an indication of periodontitis, an inflammatory disease of the tissues that surround and support the teeth. Bacterial plaque attacks the bone, meaning teeth can loosen over time and in the worst case even fall out, as they are left without a solid foundation to hold them in place.

4 Jan 2013

Nanoparticle researcher to deliver inaugural presentation at next ACS national meeting

A noted researcher in nanomedicine ― preventing, diagnosing and treating disease with particles so small that thousands fit across the width of a human hair ― will deliver the inaugural presentation in "The Kavli Foundation Emerging Leader in Chemistry Lecture" at the next National Meeting of the American Chemical Society (ACS).

4 Jan 2013

Color of containers where food and drink are served can enhance attributes like taste and aroma

Two researchers from the Polytechnic University of Valencia and the University of Oxford have proven that hot chocolate tastes better in an orange or cream coloured cup than in a white or red one. The study adds to recent research demonstrating how our senses perceive food in a different way depending on the characteristics of the container from which we eat and drink.

4 Jan 2013

Costs and benefits of bigger brains

Bigger brains can make animals, well, brainier, but that boost in brain size and ability comes at a price. That's according to new evidence reported on January 3rd in Current Biology, a Cell Press publication, in which researchers artificially selected guppies for large and small brain sizes.

4 Jan 2013

Journalists may now apply for press credentials for ACS's 245th National Meeting & Exposition

Journalists may now apply for press credentials for the American Chemical Society's 245th National Meeting & Exposition. One of the largest scientific conferences of the New Year will be held April 7-11, 2013, in New Orleans, La.

4 Jan 2013

March of Dimes book offers scientifically-based advice for pregnant women, tips for new parents

Taking a daily multivitamin containing the B vitamin folic acid is one of the best ways to prevent birth defects and an important step toward having a healthy baby, yet only about one-third of women know about it.

4 Jan 2013

Top 4 reasons why many dieters do not lose weight

The battle of the bulge is on - any movement on the scale yet? "Losing weight is one of the top resolutions made every year, yet only 20 percent of people achieve successful weight-loss and maintenance," says Jessica Bartfield,MD, internal medicine who specializes in nutrition and weight management at the Loyola Center for Metabolic Surgery & Bariatric Care.

4 Jan 2013

Paratek receives FDA QIDP designation for omadacycline to treat ABSSSI, CABP

Paratek Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated the Company's lead antibiotic candidate, omadacycline (formerly known as PTK 0796), as a Qualified Infectious Disease Product (QIDP) for both intravenous (IV) and oral formulations in the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).

3 Jan 2013

FDA approves Abbott’s XIENCE Xpedition Everolimus Eluting Coronary Stent System

Abbott today announced that the XIENCE Xpedition Everolimus Eluting Coronary Stent System received U.S. Food and Drug Administration (FDA) approval and is launching immediately in the United States, providing physicians with a next-generation technology with the largest size matrix in the U.S. market.

3 Jan 2013

A little extra fat could be protective

A review of almost 100 studies found that people who were overweight or slightly obese had a lower risk of dying compared to those considered "normal" weight.

3 Jan 2013

FDA grants accelerated approval to drug to treat MDR-TB

"The U.S. Food and Drug Administration on Monday approved Johnson & Johnson's drug to treat a form of resistant tuberculosis that is uncommon in the U.S. but growing globally," the Wall Street Journal reports.

3 Jan 2013

Improving research on BPA chemical may lead to better guidelines for human health

Following a three-year study using more than 2,800 mice, a University of Missouri researcher was not able to replicate a series of previous studies by another research group investigating the controversial chemical BPA. The MU study is not claiming that BPA is safe, but that the previous series of studies are not reproducible.

3 Jan 2013

More work ahead in TB drug development, treatment delivery

The U.S. Food and Drug Administration's approval of the tuberculosis (TB) drug Sirturo, also known as bedaquiline, "appears to be just the first step in an exciting renaissance for TB drug development," Mark Harrington, executive director of Treatment Action Group (TAG), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.

3 Jan 2013

Kareus announces start of KU-046 Phase I study in Alzheimer's

Kareus Therapeutics SA, the private biotechnology company focused on the development of novel therapeutics for the unmet treatment of age-related and chronic diseases, today announces the start of a Phase I clinical study following the Investigational New Drug (IND) approval from the US Food and Drug Administration for the development of KU-046, a first-in-class disease modifying new chemical entity discovered for the treatment of Alzheimer's disease using Kareus' proprietary bioenergetics and KARLECT platforms.

3 Jan 2013

UMDNJ-School of Osteopathic Medicine establishes Biomarker Discovery Center

Following recent discoveries by its researchers that could significantly change the diagnosis and treatment of a number of diseases, the University of Medicine and Dentistry of New Jersey (UMDNJ)-School of Osteopathic Medicine has established the Biomarker Discovery Center on its Stratford campus.

3 Jan 2013

FDA acknowledges resubmission of Merck’s NDA for ezetimibe and atorvastatin tablets

Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has acknowledged the resubmission of a New Drug Application (NDA) for ezetimibe and atorvastatin tablets, an investigational combination medicine.

3 Jan 2013

Salix receives FDA approval for crofelemer to treat HIV-associated diarrhea

On New Year's Eve of 2012, the US Food and Drug Administration (FDA) announced its approval of crofelemer (Fulyzaq, Salix Pharmaceuticals, Ltd., Raleigh, North Carolina) — marking the second time a botanical, and the first time an orally administered botanical, has received drug approval from the Administration.

3 Jan 2013

Bristol-Myers Squibb, Pfizer receive FDA approval for ELIQUIS to reduce risk of stroke and SE

Bristol-Myers Squibb Company and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) approved ELIQUIS (apixaban) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

2 Jan 2013

Food News and Research

1 in 4 survey participants secretly create concoctions

Confusion surrounds regulation of various types of drug makers

ParoChip can allow dentists to quickly detect and analyze periodontitis pathogens

Nanoparticle researcher to deliver inaugural presentation at next ACS national meeting

Color of containers where food and drink are served can enhance attributes like taste and aroma

Costs and benefits of bigger brains

Journalists may now apply for press credentials for ACS's 245th National Meeting & Exposition

March of Dimes book offers scientifically-based advice for pregnant women, tips for new parents

Top 4 reasons why many dieters do not lose weight

Paratek receives FDA QIDP designation for omadacycline to treat ABSSSI, CABP

FDA approves Abbott’s XIENCE Xpedition Everolimus Eluting Coronary Stent System

A little extra fat could be protective

FDA grants accelerated approval to drug to treat MDR-TB

Improving research on BPA chemical may lead to better guidelines for human health

More work ahead in TB drug development, treatment delivery

Kareus announces start of KU-046 Phase I study in Alzheimer's

UMDNJ-School of Osteopathic Medicine establishes Biomarker Discovery Center

FDA acknowledges resubmission of Merck’s NDA for ezetimibe and atorvastatin tablets

Salix receives FDA approval for crofelemer to treat HIV-associated diarrhea

Bristol-Myers Squibb, Pfizer receive FDA approval for ELIQUIS to reduce risk of stroke and SE

The future is bioengineered: Synthetic biology and global sustainability eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News